Maxim Integrated Products (MXIM): Chip Recovery Has Begun - Wells Fargo
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Wells Fargo analyst, David Wong, reiterated his Market Perform rating on shares of Maxim Integrated Products (NASDAQ: MXIM) and raised his valuation range to $34.00 to $40.00 from $27 to $34 after Maxim’s December sales outlook implied a return to year/year growth. This supports the analyst's view that a recovery in chip demand has begun.
The analyst raised his FY’17 EPS estimate to $1.85 from $1.82 (with the upside being driven primarily by special gains for a business sale in the September quarter). The FY’18 EPS estimate remains unchanged at $2.10.
Shares of Maxim Integrated Products closed at $39.10 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- M&T Bank (MTB) PT Raised to $165 at FBR Capital Following 4Q Beat
- PacWest Bancorp (PACW) PT Raised to $60.50 at FIG Partners Following 4Q Report
- J.B. Hunt Transport Services (JBHT) PT Lowered to $99 at UBS Following 4Q EPS Miss
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS Change, Analyst PT Change, Earnings
Related EntitiesWells Fargo
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!